United States · FDA National Drug Code directory
Obagi Skintrinsiq Antioxidant Protocol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62032-907_8299732b-f96d-45fe-ae06-058f296cad1e
- Product NDC
- 62032-907
- Form
- KIT
- Composition / generic term
- AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, and OXYBENZONE
- Labeler
- Obagi Cosmeceuticals LLC
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20210801
- Source listing expiry
- 20271231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
Package details are not available in this snapshot.
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →